Mutual funds holding Emcure Pharmaceuticals
Healthcare · Small Cap. From each fund's Aug 2026 portfolio.
Funds holding it
25
24 active, 1 index
Held by these funds
₹2,274 Cr
approx., weight × fund size
Largest weight, active fund
3.84%
Bajaj Finserv Healthcare Fund
Every fund holding Emcure Pharmaceuticals
| Fund | Category | Weight in fund | Value held |
|---|---|---|---|
| Sector Specific - Pharma | 3.84% | ₹15.56 Cr | |
| Sector Specific - Pharma | 2.99% | ₹32.22 Cr | |
| Tax Savings | 2.57% | ₹2.67 Cr | |
| Small Cap | 2.42% | ₹30.91 Cr | |
| Sector Specific - Pharma | 2.38% | ₹11.60 Cr | |
| Small Cap | 1.88% | ₹5.07 Cr | |
| Tax Savings | 1.72% | ₹233 Cr | |
| Sector Specific - Pharma | 1.57% | ₹12.95 Cr | |
| Solution Oriented - Retirement | 1.25% | ₹5.82 Cr | |
| Sector Specific - Pharma | 1.25% | ₹115 Cr | |
| Small Cap | 1.17% | ₹71.60 Cr | |
| Mid Cap | 1.12% | ₹746 Cr | |
| Multi - Cap | 1.08% | ₹78.24 Cr | |
| Solution Oriented - Children's Fund | 1.04% | ₹12.45 Cr | |
| Thematic - Business Cycles | 0.93% | ₹12.50 Cr | |
| Flexi - Cap | 0.90% | ₹199 Cr | |
| Sector Specific - Pharma | 0.89% | ₹12.73 Cr | |
| Small Cap | 0.86% | ₹159 Cr | |
| Large & Mid Cap | 0.85% | ₹47.62 Cr | |
| Equity Savings Fund | 0.62% | ₹5.30 Cr | |
| Multi - Cap | 0.54% | ₹290 Cr | |
| Small Cap | 0.48% | ₹147 Cr | |
| Multi Asset Allocation | 0.44% | ₹11.51 Cr | |
| Index - Sector & Thematic | 0.39% | ₹8.14 L | |
| Thematic - Dividend Yield | 0.30% | ₹15.82 Cr |
Look up another stock
How many mutual funds hold Emcure Pharmaceuticals?
25 mutual funds held Emcure Pharmaceuticals in their Aug 2026 portfolios: 24 actively managed funds and 1 index funds and ETFs.
Which mutual fund has the highest holding in Emcure Pharmaceuticals?
By weight in the fund, the largest actively managed holders are Bajaj Finserv Healthcare Fund, Aditya Birla Sun Life Pharma and Healthcare Fund, Samco ELSS Tax Saver Fund.
Where does this data come from?
Each fund's latest monthly portfolio disclosure. Value held is the stock's weight in the fund multiplied by the fund's assets, so it is approximate.
See also portfolio overlap between two funds. Not a recommendation to buy or sell any stock or fund.